Skip to main navigation
Skip to main content
Skip to Footer
Global
Novartis Site Directory
Our Services
Assay Development for Intended Use
Clinical Trial Testing
Companion Diagnostics Solutions
Partnership Opportunitites
Portfolio
Our Company
Who We Are
Leadership
Join Us
Contact
Our Capabilities
Technical
Project Management
Data Management
Global Logistics
Portfolio
Lab Partnerships
Companion Diagnostics Partners
Service Inquiries
Our Experience
Navigate Team
Publications
Services Metrics
Quality
Search
News Archive
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Stories
Filter By
2015
September
Media Release
/
Sep 24, 2015
Read More
Media Release
/
Sep 24, 2015
Novartis launches 'Novartis Access', a portfolio of affordable medicines to treat chronic diseases in lower-income countries
Read More
Media Release
/
Sep 18, 2015
Swissmedic approves Novartis' new heart failure medicine Entresto(TM)
Read More
Media Release
/
Sep 07, 2015
Novartis Foundation healthcare models and disease elimination programs showcased at ECTMIH
Read More
Media Release
/
Sep 04, 2015
Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma
Read More
Media Release
/
Sep 03, 2015
Sandoz launches ZarxioTM (filgrastim-sndz), the first biosimilar in the United States
Read More
Media Release
/
Sep 02, 2015
Novartis receives EU approval for new Revolade® use as first-in-class therapy for patients with severe aplastic anemia
Read More
Media Release
/
Sep 01, 2015
Novartis announces global partnership with Amgen to develop and commercialize pioneering neuroscience treatments
Read More
Media Release
/
Sep 01, 2015
Read More
Media Release
/
Sep 01, 2015
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
Page
1
of 5
Current page
2
of 5
Page
3
of 5
Page
4
of 5
Page
5
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
Print
Save
You are here
Home
›